Skip to main content

Long Term Usage

 




A new study out of Finland, as reported on May 14, 2025, reveals that children diagnosed with ADHD are staying on medication far longer than we’ve ever had reliable data for—and yet the safety net of clinical evidence hasn’t kept pace. On average, kids in the Finnish cohort remain medicated for more than three years, and those in the top decile endure treatment for over seven years.

Imagine handing someone a pair of wings without teaching them to fly—and now envision those wings strapped on for years without knowing how they affect the body. The study lead, Päivi Ruokoniemi, says, “a significant proportion of young children, especially boys, are on ADHD medication for years, throughout their comprehensive school years.” That’s not just care—that’s a long flight into the unknown. Yet, the regulatory safety net only extends to a one‑year randomized study window. After that, we’re essentially gliding blind.

Boys start younger and stick around longer. The largest group—boys diagnosed at age 6 to 8—clock in at a median of 6.3 years on meds, and for a quarter of them it’s over 9.4 years. The metaphor that springs to mind is a young tree planted before its roots can settle—incoming winds may bend it, but we don’t really know if it blooms stronger or snaps in the storm.

The researchers highlight a disquieting gap: “The long‑term effects of ADHD medicines have been studied extensively in various observational and uncontrolled research settings, but these are always prone to confounding and therefore do not provide reliable information on cause‑and‑effect relationships.” In plain English: we’re missing the proof we need for what happens when this medicine becomes a steady companion for most of childhood.

On top of that, there’s the subtle pressure of norms setting in. As the article notes, regulatory authorities only demand safety data for one year, meaning once that year is up, many children keep going—and no one really knows how the journey affects them long term.

Beyond the numbers, there’s an ethical imperative. Ruokoniemi urges that ADHD meds be kicked off only when non‑pharmacological treatments fall short—and that annual reviews by a physician be standard practice. Parents and kids, she stresses, must be given enough “information on the expected benefits and harms of the medicine and the uncertainties associated with them.” That’s akin to checking altitude on a flight simulator—information gives you the ability to course‑correct.

Now, I know what you’re thinking—because I said it myself: aren’t ADHD meds basically just meth in a prescription bottle? And listen, I’ve tried meth a couple times (not exactly a résumé builder, I know), so I get why that comparison might raise some eyebrows. After a couple runs with the real thing, popping an Adderall can feel suspiciously familiar. But here’s the thing: while meds like Ritalin and amphetamines are chemically related to methamphetamine, they’re more like the responsible, sober cousin who went to med school. They’re formulated, dosed, and monitored in clinical settings, and they play by a totally different rulebook—FDA-approved, prescribed by doctors, and (ideally) taken under careful supervision. So yeah, I can joke about it, but I also know there’s a big difference between what I was doing and what a kid with ADHD is prescribed. Even if my brain sometimes blurs the lines, the science doesn’t.

Still, the metaphor is powerful: both substances act on the brain’s dopamine system, and when someone with no tolerance takes an illicit dose, the effect can be a jarring fireworks display. In contrast, when psychiatrists prescribe, it’s more like controlled fireworks in a stadium—with buffers, boundaries, and dismissal of the reckless.

This Finnish study shines a vivid light on something that’s felt but under‐observed—the silent elongation of ADHD treatment through formative childhood years. Without robust long‑term safety trials, it’s a flight without instruments. It’s essential that every year the child takes meds, doctors, parents, and young patients revisit the decision with fresh eyes and informed minds.

To quote Ruokoniemi: when uncertainties linger, “it must be ensured that both the caregiver and the child… have access to sufficient information on the expected benefits and harms… and the uncertainties associated with them.” That’s where wisdom takes root—and where data has to catch up before routine becomes risk.

Link to the article: https://www.sciencedaily.com/releases/2025/05/250514180742.htm

Comments

Popular posts from this blog

Cocaine Cola and Recovery

  Buy Cocaine Cola  The first time I held a composition notebook in my hands at rehab, I felt like a soldier clutching a sword in a battle I wasn’t sure I could win. Recovery—from alcoholism, from myself—was not the hero’s journey I had romanticized in my more delusional moments. It was more like crawling through a swamp with a broken compass. And yet, somehow, amid the sweat-soaked nightmares and the relentless peeling back of layers I had spent years constructing, I found the spark to create. Let me start at the beginning—or rather, one of the beginnings. You see, alcoholism has a funny way of offering you new beginnings all the time, but they’re never the kind you want. I had just hit one of those new beginnings, a rock bottom that made me look at myself and think, “This can’t be it. This cannot be how the story ends.” The days leading up to rehab are a blur, like a badly edited montage of shame, regret, and staggering attempts at normalcy. But once I walked through those ...

Demons Within - Out Now!

  Buy Now Demons Within is a fictional story that hits on the true madness of alcoholism and addiction. Written through the lens of a crime thriller, the storyline takes place in the Capitol region of New York State and features a series of twists and turns. The protagonist, Bill Dillard, is a retired homicide detective who has struggled with alcoholism and addiction for the past two decades. His drinking destroyed his marriage, strained his relationships, and left him alone in the world. Yet after his ex-wife is found brutally murdered in a cabin in upstate New York, Bill finds himself thrust into the investigation, determined to uncover the truth. As the plot ramps up, Bill’s disease brings him to the depths of despair, including his ultimate rock bottom, before finding the strength to pull himself up in order to solve the crime. This riveting, unputdownable, engrossing page-turner is available now in Hardcover, Paperback, and eBook - exclusively on Amazon.  Now

My Books

  My Books **Discover Worlds Beyond Your Imagination**   Step into the library of my mind—a place where stories run wild, characters come alive, and each book is a doorway to a different world. From the crackle of a freshly turned page to the glow of your favorite device, these tales are waiting for you to dive in.   Imagine holding a map that leads to laughter, heartbreak, mystery, or adventure. That’s what you’ll find here—books that whisper, shout, and sing. Each one is crafted with care, shaped by midnight musings and coffee-fueled mornings.   Amazon may be the bustling metropolis where most of you stop by, but these stories stretch far and wide—Barnes & Noble, Apple Books, Kobo, and more. No matter where you like to read, there’s a seat waiting for you.   Ready to explore? Click “My Books” at the top or bottom of this page and see what’s waiting for you. Each book is a ticket. All you have to do is choose your destination.   My Books